The Functional and Emotional Benefits of Replenix Power of Three With Resveratrol
Clinical trial NCT03563365 · TERMINATED
Trial details
- NCT number
- NCT03563365
- Sponsor
- Yardley Dermatology Associates
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-04
- Primary completion
- 2021-03-02
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.